Pancreatic Adenocarcinoma Signature Stratification for Treatment

Clinical trial NCT04469556 · COMPLETED

Trial details

NCT number: NCT04469556
Sponsor: University Health Network, Toronto
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Metastatic Pancreatic Ductal Adenocarcinoma Advanced Pancreatic Cancer

Start date: 2020-10-14
Primary completion: 2025-03-05
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.